A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 242
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : AMP
Long Form : amphetamine
No. Year Title Co-occurring Abbreviation
2020 Graphene oxide-Fe3O4 nanocomposite magnetic solid phase extraction followed by UHPLC-MS/MS for highly sensitive determination of eight psychoactive drugs in urine samples. 6-MAM, BZE, GO-Fe3O4, LOD, LOQ, MAMP, MOR, MSPE
2019 An Open-Label, Multicenter, Single-Dose Pharmacokinetic Study of a Novel Amphetamine Extended-Release Orally Disintegrating Tablet in Preschool-Aged Children. ADHD, AMP XR-ODT, PKs, Tmax
2019 An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations. ADHD, ER, MPH
2019 Determination of amphetamine-type stimulants in urine samples using microextraction by packed sorbent and gas chromatography-mass spectrometry. GC-MS, MAMP, MDA, MDE, MDMA, MEPS, RE
2019 Developed nano carbon-based coating for simultaneous extraction of potent central nervous system stimulants from urine media by stir bar sorptive extraction method coupled to high performance liquid chromatography. MET, MTMOS, SBSE, TEOS
2019 Drug screening using the sweat of a fingerprint: lateral flow detection of Delta9-tetrahydrocannabinol, cocaine, opiates and amphetamine. THC
2019 Dynamic interactions of ceftriaxone and environmental variables suppress amphetamine seeking. CTX, EC, GLT1, mPFC, NAc, SC
2019 Multi-residue method for enantioseparation of psychoactive substances and beta blockers by gas chromatography-mass spectrometry. ALP, EF, GC-MS, LOD, LOQ, MAMP, MDMA, MET, NFLX, PAR, SER
2019 New Formulations of Stimulants: An Update for Clinicians. ADHD, MPH
10  2019 Wastewater-based monitoring of illicit drug consumption in Istanbul: Preliminary results from two districts. COC, MDMA, METH
11  2018 Association between cytochrome P450 2D6 polymorphisms and body fluid methamphetamine concentrations in Japanese forensic autopsy cases. CYP2D6, EM, IM, MA, PM, UM
12  2018 Chiral analysis of amphetamines in hair by liquid chromatography-tandem mass spectrometry: compliance-monitoring of attention deficit hyperactivity disorder (ADHD) patients under Elvanse therapy and identification after controlled low-dose application. ADHD, DFC, HPLC
13  2018 In Situ Determination of Illegal Drugs in Oral Fluid by Portable Capillary Electrophoresis with Deep UV Excited Fluorescence Detection. CBD, CE, FD, MDA, MDEA, MDMA, METH, PMA, PMMA, THC
14  2018 Keratinous matrices for the assessment of drugs of abuse consumption: A correlation study between hair and nails. 6-MAM, BE, COC, COD, EDDP, EME, MDMA, MOR, MTD
15  2018 LC-MS-MS Method Development and Analysis of Stimulants, Opiates, Synthetic Opiates, PCP, and Benzodiazepines in Wastewater. Preponderance of these Drugs During Football Games. COC, LC-MS-MS, MDA, MDEA, MDMA, METH, MS
16  2018 Oxidized multiwalled carbon nanotubes coated fibers for headspace solid-phase microextraction of amphetamine-type stimulants in human urine. ATSs, CNTs, GC-MS, MAMP, SPME
17  2018 Pharmacokinetics of a New Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder. ADHD, CIs, PK
18  2018 Response-inhibition capacity in spontaneously hypertensive and Wistar rats: acquisition of fixed minimum interval performance and responsiveness to D-amphetamine. FMI, IRT, SHR
19  2018 SUPRAS extraction approach for matrix-independent determination of amphetamine-type stimulants by LC-MS/MS. ATS, LLOQ, MA, MDA, MDEA, MDMA, SUPRAS
20  2017 A Randomized Phase I Study to Assess the Effect of Alcohol on the Pharmacokinetics of an Extended-release Orally Disintegrating Tablet Formulation of Amphetamine in Healthy Adults. ADHD
21  2017 Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine. ADHD, ATX, CI, HR, MPH, SMD
22  2017 Comparison of 3 Derivatization Methods for the Analysis of Amphetamine-Related Drugs in Oral Fluid by Gas Chromatography-Mass Spectrometry. CAT, HFBA, IS, MA, MDA, MDEA, MDMA, PFPA, TFAA
23  2017 Differentiation of ring-substituted regioisomers of amphetamine and methamphetamine by supercritical fluid chromatography. MA, SFC
24  2017 Drugs of abuse and their metabolites in the urban rivers of Beijing, China: Occurrence, distribution, and potential environmental risk. EPH, HY, KET, METH
25  2017 Investigation and Application of a New Passive Sampling Technique for in Situ Monitoring of Illicit Drugs in Waste Waters and Rivers. DGT, KET, METH
26  2017 One-Step Derivatization-Extraction Method for Rapid Analysis of Eleven Amphetamines and Cathinones in Oral Fluid by GC-MS. EPH, MA, MDMA
27  2017 Regional differences in dopamine receptor blockade affect timing impulsivity that is altered by d-amphetamine on differential reinforcement of low-rate responding (DRL) behavior in rats. dHip, DRL, mPFC, NAc
28  2017 The Clinical Pharmacokinetics of Amphetamines Utilized in the Treatment of Attention-Deficit/Hyperactivity Disorder. ADHD, FDA, IR, PubMed
29  2017 [Distribution Characteristics of Drugs of Abuse and Their Metabolites in Aqueous Environment of Beijing, China]. EPH, HY, KET, MC, METH
30  2016 A solid colorimetric sensor for the analysis of amphetamine-like street samples. MAMP, MDA, MDMA, NQS
31  2016 Chronic treatment of (+)-methamphetamine-induced locomotor effects in rats using one or a combination of two high affinity anti-methamphetamine monoclonal antibodies. mAb, METH
32  2016 Determination of amphetamines in hair by integrating sample disruption, clean-up and solid phase derivatization. EPE, FMOC, LC, LODs, MDMA, MET, MSPD
33  2016 LC-MS-MS Method for Stimulants in Wastewater During Football Games. COC, LC-MS-MS, MDA, MDEA, MDMA, METH, MS
34  2016 One Hundred False-Positive Amphetamine Specimens Characterized by Liquid Chromatography Time-of-Flight Mass Spectrometry. HRMS, IA, TOF
35  2015 Application of Physiologically Based Absorption Modeling for Amphetamine Salts Drug Products in Generic Drug Evaluation. BE, ER, PK
36  2015 Effects of prenatal immune activation on amphetamine-induced addictive behaviors: Contributions from animal models. COC
37  2014 A high-throughput method based on microwave-assisted extraction and liquid chromatography-tandem mass spectrometry for simultaneous analysis of amphetamines, ketamine, opiates, and their metabolites in hair. 6-AM, COD, DHNK, LC-MS-MS, MA, MAE, MDA, MDMA, MOR, NK, SD, TFA
38  2014 Acute total sleep deprivation potentiates amphetamine-induced locomotor-stimulant effects and behavioral sensitization in mice. PSD
39  2014 Affinity improvement of a therapeutic antibody to methamphetamine and amphetamine through structure-based antibody engineering. METH
40  2014 Comparing stimulant effects in youth with ADHD symptoms and epilepsy. MPH
41  2014 Effect of amphetamine on adult male and female rats prenatally exposed to methamphetamine. CORT, CPP, EIA, MA, MWM
42  2014 Elevated BDNF mRNA expression in the medial prefrontal cortex after d-amphetamine reinstated conditioned place preference in rats. BDNF, CPP, DA, mPFC, PCR
43  2014 Estimation of amphetamine and methamphetamine uses in Beijing through sewage-based analysis. METH, STPs
44  2014 Evaluation of commercial multi-drug oral fluid devices to identify 39 new amphetamine-designer drugs. MET, OF, OFDs
45  2014 Gender differences in the effect of adult amphetamine on cognitive functions of rats prenatally exposed to methamphetamine. MA, MWM, SA
46  2014 Occurrence and removal of drugs of abuse in Wastewater Treatment Plants of Valencia (Spain). BECG, COC, KET, MAMP, MDMA, RQ, WWTP
47  2014 Sex differences in methamphetamine pharmacokinetics in adult rats and its transfer to pups through the placental membrane and breast milk. METH
48  2014 Simultaneous analysis of amphetamine-type stimulants in plasma by solid-phase microextraction and gas chromatography-mass spectrometry. ATS, DIE, FEN
49  2014 The Ergogenic Effect of Amphetamine. Amp-1
50  2013 D-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptors. LI, WT
51  2013 Identifying methamphetamine exposure in children. MAMP, MDA, MDEA, MDMA, OF
52  2012 Differential effects of intermittent and continuous exposure to novel environmental stimuli on the development of amphetamine-induced behavioral sensitization in mice: implications for addiction. ---
53  2012 Effect of early life housing manipulation on baseline and drug-induced behavioural responses on neurochemistry in the male rat. BDNF, DMI, DZP, EE, EPM, FST
54  2012 Fenproporex and amphetamine pharmacokinetics in oral fluid after controlled oral administration of fenproporex. FEN
55  2012 Incorporation of methamphetamine and amphetamine in human hair following controlled oral methamphetamine administration. MAMP
56  2012 Rapid analysis of abused drugs using nanostructured silicon surface assisted laser desorption/ionization mass spectrometry. COD, KET, MA, MOR, nSi, nSi-MS
57  2012 Sex differences in baseline and drug-induced behavioural responses in classical behavioural tests. APO, DMI, DZP, EPM, FST, HCMA
58  2012 The effects of isolated and enriched housing conditions on baseline and drug-induced behavioural responses in the male rat. DMI, DZP, EE, EPM, FST
59  2012 [Usefulness of AccuSign in emergency room]. MET
60  2011 A one year investigation of the occurrence of illicit drugs in wastewater from Brussels, Belgium. 6-MAM, BE, COC, EDDP, EME, MDMA, METH, MTD
61  2011 Abnormal behaviors and microstructural changes in white matter of juvenile mice repeatedly exposed to amphetamine. ---
62  2011 Applicability of an on-site test for its use in post-mortem blood. COC-F, MA, OPI-F, PPV
63  2011 Chronic amphetamine transforms the emotional significance of a novel but not a familiar environment: implications for addiction. Hab
64  2011 d-Amphetamine-induced cytotoxicity and oxidative stress in isolated rat hepatocytes. AST, BCNU, BSO, CAT, CDNB, Cys, DFO, DMSO, DTT, LDH, MT, SOD, TBARS
65  2011 Determination of amphetamine-type stimulants in oral fluid by solid-phase microextraction and gas chromatography-mass spectrometry. DIE, FEN, MET, MPH
66  2011 Differential sensitivity to amphetamine's effect on open field behavior of psychosocially stressed male rats. DOM, Sdom, SiH
67  2011 Examining the role of oxytocin in the interoceptive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') using a drug discrimination paradigm in the rat. ---
68  2011 Insights into scFv:drug binding using the molecular dynamics simulation and free energy calculation. METH, scFv
69  2011 Maternal high-fat intake alters presynaptic regulation of dopamine in the nucleus accumbens and increases motivation for fat rewards in the offspring. DA, NAc, PFC, VMAT, VTA
70  2011 Sewage epidemiology--a real-time approach to estimate the consumption of illicit drugs in Brussels, Belgium. COC, HER, MDMA, METH, MTD, WWTP
71  2011 Simultaneous determination of HFBA-derivatized amphetamines and ketamines in urine by gas chromatography-mass spectrometry. DHNK, HFBA, MAMP, MDA, MDEA, MDMA
72  2010 In silico experiments of single-chain antibody fragment against drugs of abuse. METH, scFv
73  2010 New meconium biomarkers of prenatal methamphetamine exposure increase identification of affected neonates. MAMP, NOREPH, pOHAMP, pOHMAMP
74  2010 Overview of amphetamine-type stimulant mortality data--UK, 1997-2007. METH, np-SAD
75  2010 Stereoselectivity in the human metabolism of methamphetamine. MA, pOH-MA
76  2009 False negative result for amphetamines on the Triage Drug of Abuse panel? The cause of the unusual phenomenon with experimental analyses. ---
77  2009 Novel biomarkers of prenatal methamphetamine exposure in human meconium. MAMP
78  2009 Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice. APO, OXT, PPI
79  2009 Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder. ADHD, ADHD-RS-IV, AEs, GXR, MPH
80  2009 Urine levels of drugs for which Triage DOA screening was positive. BAR, BZO, OPI, TCA
81  2008 Appetitive overshadowing is disrupted by systemic amphetamine but not by electrolytic lesions to the nucleus accumbens shell. DA, noise or tone, UCS
82  2008 Differential effects of lesions in the subareas of medial prefrontal cortex on the development of behavioral sensitization to amphetamine: the role of environmental context. mPFC
83  2008 Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039). mGlu
84  2008 Excretion of methamphetamine and amphetamine in human sweat following controlled oral methamphetamine administration. d-MAMP HCl, MAMP
85  2008 How messengers modulate the shifting of spontaneously generated action potential into bursts of potentials in central snail neuron? BoP
86  2008 Influence of amphetamine on recovery after intracerebral hemorrhage in rats. EE, ICH, NDs
87  2007 Development and validation of a disk solid phase extraction and gas chromatography-mass spectrometry method for MDMA, MDA, HMMA, HMA, MDEA, methamphetamine and amphetamine in sweat. HMA, HMMA, LOQ, MAMP, MDA, MDEA, MDMA
88  2007 Effects of environmental enrichment and paradoxical sleep deprivation on open-field behavior of amphetamine-treated mice. EC, PSD, SC
89  2007 Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats. Arc, mGluR1, RT-PCR, SCH, SKF, YM
90  2007 [Detecting methamphetamine and amphetamine with high performance liquid chromatography]. HPLC, MA
91  2006 A validated gas chromatographic-electron impact ionization mass spectrometric method for methylenedioxymethamphetamine (MDMA), methamphetamine and metabolites in oral fluid. HMA, HMMA, MAMP, MDA, MDEA, MDMA, SIM
92  2006 Amphetamine-elicited striatal Fos expression is attenuated in neurotensin null mutant mice. NT
93  2006 Amphetamine-induced rapid-onset sensitization: role of novelty, conditioning and behavioral parameters. SAL
94  2006 Amphetamines as potential inducers of fatalities: a review in the district of Ghent from 1976-2004. 4-MTA, MDA, PMA
95  2006 Characterization of the rapid-onset type of behavioral sensitization to amphetamine in mice: role of drug-environment conditioning. LSE, ROBS, SB
96  2006 Determination of amphetamine and methamphetamine in urine by solid phase extraction and ion-pair liquid chromatography-electrospray-tandem mass spectrometry. MAMP, SPE
97  2006 Drug-induced home cage conspecifics' behavior can potentiate behavioral sensitization in mice. EtOH
98  2006 Occupational exposure to methamphetamine in workers preparing training AIDS for drug detection dogs. MTH
99  2006 Prevalence of use study for amphetamine (AMP), methamphetamine (MAMP), 3,4-methylenedioxy-amphetamine (MDA), 3,4-methylenedioxy-methamphetamine (MDMA), and 3,4-methylenedioxy-ethylamphetamine (MDEA) in military entrance processing stations (MEPS) specimens. IA, MAMP, MDA, MDEA, MDMA, MEPS
100  2006 Quantitative determination of total methamphetamine and active metabolites in rat tissue by liquid chromatography with tandem mass spectrometric detection. LOQ, METH, MS/MS